Patient-Centered Management of Dyslipidemia: Part 1

Published: April 2016
  Looking for subscriptions?
  • Key Points
  • Risk Assessment
  • Treatment Recommendations
  • Algorithms
    • Model of Steps in Lifestyle Therapies
    • Progression of Atherogenic-Cholesterol-Lowering Drug Therapy
  • Tables
    • Criteria for Classification of ASCVD
    • Major Risk Factors for ASCVD
    • Risk Calculators
    • Criteria for ASCVD Risk Assessment, Treatment Goals for Atherogenic Cholesterol, and Levels at Which to Consider Drug Therapy
    • High or Very High-Risk Patient Groups
    • Sequential Steps in ASCVD Risk Assessment
    • Classifications of Cholesterol and Triglyceride Levels
    • Drugs That May Elevate LDL-C or Triglyceride Concentrations
    • Risk Indicators (Other Than Major ASCVD Risk Factors) That Might be Considered for Risk Refinement
    • Diet Characteristics and Diseases/Disorders/Altered Metabolic States That May Elevate LDL-C and/or Triglyceride Concentrations
    • Criteria for Clinical Identification of the Metabolic Syndrome
    • Treatment Goals for Non-HDL-C, LDL-C, and Apo B
    • The intensity of Statin Therapy
    • Apheresis
    • Available drugs and Their Effects on Lipid Metabolism
    • Agents for Homozygous Familial Hypercholesterolemia
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The National Lipid Association (NLA) is a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine. The NLA represents more than 3,500 members in the United States and provides continuing medical education for physicians and other healthcare professionals to advance professional development and attain certification in clinical lipidology. The NLA's public health mission is to help reduce deaths related to high cholesterol, and the Association defines "clinical lipidology" as "a multidisciplinary branch of medicine focusing on lipid and lipoprotein metabolism and their associated disorders."


This pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.


Digital Download Information:
  • Supported on Apple and Android devices
  • Content is accessible offline
  • PDF Format
  • Download instantly from your account
Need help?